Brian Clagett

1.9k total citations
23 papers, 1.5k citations indexed

About

Brian Clagett is a scholar working on Virology, Emergency Medicine and Immunology. According to data from OpenAlex, Brian Clagett has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 7 papers in Emergency Medicine and 7 papers in Immunology. Recurrent topics in Brian Clagett's work include HIV Research and Treatment (14 papers), HIV-related health complications and treatments (7 papers) and Immune Cell Function and Interaction (5 papers). Brian Clagett is often cited by papers focused on HIV Research and Treatment (14 papers), HIV-related health complications and treatments (7 papers) and Immune Cell Function and Interaction (5 papers). Brian Clagett collaborates with scholars based in United States, Sweden and Australia. Brian Clagett's co-authors include Nicholas Funderburg, Michael M. Lederman, Benigno Rodríguez, Janet Robinson, Grace A. McComsey, Carey L. Shive, Peter W. Hunt, Steven G. Deeks, Jeffrey N. Martin and Ying Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the American College of Cardiology.

In The Last Decade

Brian Clagett

21 papers receiving 1.5k citations

Peers

Countries citing papers authored by Brian Clagett

Since Specialization

Citations

This map shows the geographic impact of Brian Clagett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Clagett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Clagett more than expected).

Fields of papers citing papers by Brian Clagett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Clagett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Clagett. The network helps show where Brian Clagett may publish in the future.

Co-authorship network of co-authors of Brian Clagett

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Clagett. A scholar is included among the top collaborators of Brian Clagett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Clagett. Brian Clagett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interleukin-2 is a potent latency reversal agent in people with treated HIV-1 2025 ·Science Advances ·Michael L. Freeman, Brian Clagett, Konstantin Leskov, Daniela Moïsi, George A. Yendewa, Scott F. Sieg, Gregory M. Laird, Jonathan Karn, Jeffrey M. Jacobson, Benigno Rodríguez, Michael M. Lederman	0
2	Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV 2024 ·Cell Reports Medicine ·Timothy J. Henrich, Ronald J. Bosch, Catherine Godfrey, Hanna Mar, (unknown), Michael C. Keefer, Carl J. Fichtenbaum, Daniela Moïsi, Brian Clagett, Amanda M. Buck, Amelia N. Deitchman, (unknown), Jonathan Z. Li, Daniel R. Kuritzkes, Michael M. Lederman, Priscilla Y. Hsue, Steven G. Deeks, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	5
3	Inflammation and Microbial Translocation Correlate with Reduced MAIT Cells in People with HIV 2024 ·SHILAP Revista de lepidopterología ·(unknown), Brian Clagett, M. J. Freeman	2
4	Trained mesenchymal stromal cell-based therapy HXB-319 for treating diffuse alveolar hemorrhage in a pristane-induced murine model 2024 ·Stem Cells ·Hülya Bükülmez, Adrienne T. Dennis, (unknown), Scott F. Sieg, Brian Clagett, (unknown), (unknown), Nora G. Singer, Mark R. Chance, Kristin B. Highland, Steven N. Emancipator	0
5	Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV 2022 ·Frontiers in Immunology ·Michael L. Freeman, Brian Clagett, Daniela Moïsi, (unknown), Charles D. Morris, (unknown), Benigno Rodríguez, James H. Stein, Steven G. Deeks, Judith S. Currier, Priscilla Y. Hsue, Donald D. Anthony, Leonard H. Calabrese, Heather J. Ribaudo, Michael M. Lederman	7
6	Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial 2017 ·SHILAP Revista de lepidopterología ·Pablo F. Belaunzarán-Zamudio, Livio Azzoni, David H. Canaday, (unknown), Brian Clagett, Mohammed Rassool, Benigno Rodríguez, Ian Sanne, Irini Sereti, Juan Sierra‐Madero, Michael M. Lederman	5
7	Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection 2017 ·Vaccine ·Carey L. Shive, (unknown), Brian Clagett, Robert C. Kalayjian, Melissa Osborn, Kenneth E. Sherman, Carl J. Fichtenbaum, Rajesh T. Gandhi, Minhee Kang, Daniel L. Popkin, Scott F. Sieg, Michael M. Lederman, Benigno Rodríguez, Donald D. Anthony	16
8	INFLUENCE OF SACUBITRIL/VALSARTAN ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE WITH REDUCED EJECTION FRACTION 2017 ·Journal of the American College of Cardiology ·Jelena Seferović, Sara B. Seidelmann, Brian Clagett, Milton Packer, Michael R. Zile, Jean L. Rouleau, Karl Swedberg, Martin Lefkowitz, Victor Shi, Akshay S. Desai, John J.V. McMurray, Scott D. Solomon	1
9	A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy 2017 ·Open Forum Infectious Diseases ·Meagan P. O’Brien, Peter W. Hunt, Douglas Kitch, Karin L. Klingman, James H. Stein, Nicholas Funderburg, Jeffrey S. Berger, Pablo Tebas, Brian Clagett, Daniela Moïsi, Netanya S. Utay, (unknown), Judith A. Aberg	62
10	The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1 2016 ·AIDS Research and Human Retroviruses ·Jeffrey M. Jacobson, Steven E. Bosinger, Minhee Kang, Pablo F. Belaunzarán-Zamudio, Roy M. Matining, Cara C. Wilson, Charles Flexner, Brian Clagett, Jill Plants, Sarah Read, Lynette Purdue, Laurie Myers, (unknown), Pablo Tebas, Princy Kumar, David B. Clifford, Daniel C. Douek, Guido Silvestri, Alan Landay, Michael M. Lederman	28
11	Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·David A. Zidar, (unknown), (unknown), Brian Clagett, Heather A. Pilch-Cooper, Shawn Rose, Benigno Rodríguez, Grace A. McComsey, Scott F. Sieg, Nehal N. Mehta, Michael M. Lederman, Nicholas Funderburg	87
12	Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Carey L. Shive, Brian Clagett, (unknown), Joseph C. Mudd, Nicholas Funderburg, Michael L. Freeman, Souheil‐Antoine Younes, (unknown), Benigno Rodríguez, Grace A. McComsey, Leonard H. Calabrese, Scott F. Sieg, Michael M. Lederman	46
13	Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection 2014 ·The Journal of Infectious Diseases ·Peter W. Hunt, Elizabeth Sinclair, Benigno Rodríguez, Carey L. Shive, Brian Clagett, Nicholas Funderburg, Janet Robinson, Yong Huang, Lorrie Epling, Jeffrey N. Martin, Steven G. Deeks, Curtis L. Meinert, Mark L. Van Natta, Douglas A. Jabs, Michael M. Lederman	369
14	Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy 2014 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Nicholas Funderburg, Ying Jiang, Sara M. Debanne, Danielle Labbato, (unknown), (unknown), Brian Clagett, Janet Robinson, Michael M. Lederman, Grace A. McComsey	140
15	The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial 2013 ·Blood ·Peter W. Hunt, Nancy S. Shulman, Timothy L. Hayes, Viktor Dahl, Ma Somsouk, Nicholas Funderburg, Bridget McLaughlin, Alan Landay, Oluwatoyin Adeyemi, (unknown), Brian Clagett, Benigno Rodríguez, Jeffrey N. Martin, Timothy W. Schacker, Barbara L. Shacklett, Sarah Palmer, Michael M. Lederman, Steven G. Deeks	107
16	Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy 2013 ·Clinical Infectious Diseases ·Nicholas Funderburg, Ying Jiang, S. M. Debanne, (unknown), Danielle Labbato, Brian Clagett, Janet Robinson, M. M. Lederman, Grace A. McComsey	121
17	Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Naïve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine 2013 ·PLoS ONE ·Nicholas Funderburg, Adriana Andrade, Ellen S. Chan, Susan L. Rosenkranz, Darlene Lu, Brian Clagett, Heather A. Pilch-Cooper, Benigno Rodríguez, Judith Feinberg, Eric S. Daar, John W. Mellors, Daniel R. Kuritzkes, Jeffrey M. Jacobson, Michael M. Lederman	45
18	Circulating CD4⁺ and CD8⁺ T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation 2013 ·Immunology ·Nicholas Funderburg, (unknown), Hannah C. Sung, Gareth Hardy, Brian Clagett, James J. Ignatz-Hoover, Clifford V. Harding, Pingfu Fu, Jeffry Katz, Michael M. Lederman, Alan D. Levine	118
19	Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells 2011 ·The Journal of Infectious Diseases ·Michael M. Lederman, Leonard H. Calabrese, Nicholas Funderburg, Brian Clagett, Kathy Medvik, Hector Bonilla, Barbara Gripshover, Robert A. Salata, Alan Taege, Michelle V. Lisgaris, Grace A. McComsey, E. Kirchner, (unknown), Carey L. Shive, Robert Asaad, Robert C. Kalayjian, Scott F. Sieg, Benigno Rodríguez	254
20	Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5 2010 ·Blood ·Heather A. Pilch-Cooper, Scott F. Sieg, Thomas J. Hope, Ann Koons, Jean-Michel Escola, Robin E. Offord, Ronald S. Veazey, Donald E. Mosier, Brian Clagett, Kathy Medvik, Julie K. Jadlowsky, Mark R. Chance, Janna Kiselar, James A. Hoxie, Ronald G. Collman, Nadeene E. Riddick, Valentina Mercanti, Oliver Hartley, Michael M. Lederman	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact